Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is DIHYDROERGOTAMINE MESYLATE USP/EP, with a corresponding US DMF Number 22407.
Remarkably, this DMF maintains an Active status since its submission on January 13, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2013, and payment made on September 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II